3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow rilonacept: new trials by email Literature Review of rilonacept trials Research Report on rilonacept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IL1-TRAP, Rilonacept, in Systemic Sclerosis Rilonacept, Placebo - Scleroderma, Systemic Sclerosis | Phase 1 / Phase 2 | Completed | Boston University | 24 | 2011-12-01 | 2018-05-01 |
| Rilonacept in Diabetes Mellitus Type 1: Safety Study Rilonacept - Type 1 Diabetes Mellitus | Phase 1 | Completed | University of Texas Southwestern Medical Center | 13 | 2011-02-01 | 2014-02-24 |
| Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA) rilonacept (IL-1 Trap), Placebo - Systemic Juvenile Idiopathic Arthritis | Phase 1 | Completed | Regeneron Pharmaceuticals | 24 | 2005-11-01 | 2013-03-04 |
Arthritis, Juvenile (1) · Diabetes Mellitus, Type 1 (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1)
Boston University (1) · Regeneron Pharmaceuticals (1) · University of Texas Southwestern Medical Center (1)
United States (3)
Perrin C White, MD (1) · Robert W Simms, MD (1)